These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 32039349)

  • 1. Liver steatosis is a strong predictor of mortality and cancer in chronic hepatitis B regardless of viral load.
    Peleg N; Issachar A; Sneh Arbib O; Cohen-Naftaly M; Braun M; Leshno M; Barsheshet A; Shlomai A
    JHEP Rep; 2019 May; 1(1):9-16. PubMed ID: 32039349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diverse effects of hepatic steatosis on fibrosis progression and functional cure in virologically quiescent chronic hepatitis B.
    Mak LY; Hui RW; Fung J; Liu F; Wong DK; Cheung KS; Yuen MF; Seto WK
    J Hepatol; 2020 Oct; 73(4):800-806. PubMed ID: 32504663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic steatosis and development of type 2 diabetes: Impact of chronic hepatitis B and viral specific factors.
    Yu MW; Lin CL; Liu CJ; Huang YW; Hu JT; Wu WJ; Wu CF
    J Formos Med Assoc; 2022 Aug; 121(8):1478-1487. PubMed ID: 34764005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic steatosis in chronic hepatitis B patients is associated with metabolic factors more than viral factors.
    Peng D; Han Y; Ding H; Wei L
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1082-8. PubMed ID: 18707599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of steatosis and insulin resistance in patients with chronic hepatitis B compared with chronic hepatitis C and non-alcoholic fatty liver disease.
    Pais R; Rusu E; Zilisteanu D; Circiumaru A; Micu L; Voiculescu M; Poynard T; Ratziu V
    Eur J Intern Med; 2015 Jan; 26(1):30-6. PubMed ID: 25553983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic hepatitis B associated with hepatic steatosis, insulin resistance, necroinflammation and fibrosis.
    Yilmaz B; Koklu S; Buyukbayram H; Yalçin K; Korkmaz U; Posul E; Can G; Kurt M
    Afr Health Sci; 2015 Sep; 15(3):714-8. PubMed ID: 26957957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevalence and risk factors of hepatic steatosis in patients with chronic hepatitis B].
    Shi JP; Fan JG; Wu R; Gao XQ; Zhang L; Wang H
    Zhonghua Gan Zang Bing Za Zhi; 2008 Jul; 16(7):519-23. PubMed ID: 18647531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic steatosis: prevalence and host/viral risk factors in Iranian patients with chronic hepatitis B infection.
    Poortahmasebi V; Alavian SM; Keyvani H; Norouzi M; Mahmoodi M; Jazayeri SM
    Asian Pac J Cancer Prev; 2014; 15(9):3879-84. PubMed ID: 24935567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver steatosis in patients with chronic hepatitis B infection: host and viral risk factors.
    Minakari M; Molaei M; Shalmani HM; Mohammad Alizadeh AH; Jazi AH; Naderi N; Shavakhi A; Mashayekhi R; Zali MR
    Eur J Gastroenterol Hepatol; 2009 May; 21(5):512-6. PubMed ID: 19190500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral load speaks little about toll on liver.
    Mahtab MA; Rahman S; Khan M; Kamal M; Mamun AA; Karim MF
    Hepatobiliary Pancreat Dis Int; 2007 Oct; 6(5):483-6. PubMed ID: 17897910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe Hepatic Steatosis Is Associated With Low-Level Viremia and Advanced Fibrosis in Patients With Chronic Hepatitis B in North America.
    Ko HH; Patel NH; Haylock-Jacobs S; Doucette K; Ma MM; Cooper C; Kelly E; Elkhashab M; Tam E; Bailey R; Wong A; Minuk G; Wong P; Fung SK; Sebastiani G; Ramji A; Coffin CS
    Gastro Hep Adv; 2022; 1(1):106-116. PubMed ID: 39129930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver steatosis in children with chronic hepatitis B and C: Prevalence, predictors, and impact on disease progression.
    Pokorska-Śpiewak M; Kowalik-Mikołajewska B; Aniszewska M; Pluta M; Walewska-Zielecka B; Marczyńska M
    Medicine (Baltimore); 2017 Jan; 96(3):e5832. PubMed ID: 28099338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Liver histological status and clinic outcome in HBeAg-negative chronic hepatitis B with low viral load].
    Deng DL; Jiang JN; Su MH; Wang RM; Zang WW; Ling XZ; Wei HL; Liang XS; Zhou HK; He WM; Guo RS
    Zhonghua Gan Zang Bing Za Zhi; 2020 Dec; 28(12):1013-1017. PubMed ID: 34865348
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of chronic hepatitis B: case selection and duration of therapy.
    Leung N
    J Gastroenterol Hepatol; 2002 Apr; 17(4):409-14. PubMed ID: 11982721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inverse relationship between hepatic steatosis and hepatitis B viremia: Results of a large case-control study.
    Hui RWH; Seto WK; Cheung KS; Mak LY; Liu KSH; Fung J; Wong DK; Lai CL; Yuen MF
    J Viral Hepat; 2018 Jan; 25(1):97-104. PubMed ID: 28772340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of clinical and pathological features of chronic hepatitis B with hepatic steatosis].
    Mi YQ; Liu YG; Xu L; Fan JG; Zhang H; Ping L; Shi RF
    Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):817-20. PubMed ID: 19958639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of treatment requirement in HBeAg-negative chronic hepatitis B patients with persistently normal alanine aminotransferase and high serum HBV DNA levels.
    Ormeci A; Aydın Y; Sumnu A; Baran B; Soyer OM; Pınarbasi B; Gokturk S; Gulluoglu M; Onel D; Badur S; Akyuz F; Karaca C; Demir K; Besisik F; Kaymakoglu S
    Int J Infect Dis; 2016 Nov; 52():68-73. PubMed ID: 27619844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing hepatic steatosis distribution patterns between non-alcoholic fatty liver disease and fatty liver disease with chronic hepatitis B by second-harmonic generation/two-photon excited fluorescence method.
    Zhuang Z; Qu H; Yang W; Liu J; Wang F; Liu Y; Ding J; Shi J
    Ann Hepatol; 2020; 19(3):313-319. PubMed ID: 31870745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect modification of hepatitis B viral load on the association between metabolic risk factors and hepatic steatosis.
    Shi MY; Wong C; Lee TP
    Transl Gastroenterol Hepatol; 2023; 8():6. PubMed ID: 36704648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Correlation of hepatocyte expression of hepatitis B viral core antigen and the clinicopathological characters in chronic hepatitis B patients].
    Ding Y; Zou Z; Xu X; Zhao Z; Jia W; Fang Y; Li Y; Guo Y; Wang G
    Zhonghua Gan Zang Bing Za Zhi; 2014 Mar; 22(3):185-9. PubMed ID: 24824119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.